Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
X Financial A ADR | XYF | 4. nov 2024 | 6.61 | +0.92 |
X3 Holdings | XTKG | 4. nov 2024 | 0.11 | -0.44 |
X4 Pharmaceuticals | XFOR | 4. nov 2024 | 0.53 | +2.45 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | 4. nov 2024 | 6.87 | -0.15 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | 4. nov 2024 | 24.98 | -0.48 |
XBiotech | XBIT | 4. nov 2024 | 7.30 | -0.68 |
XBP Europe | XBP | 4. nov 2024 | 0.94 | -6.00 |
Xcel Brands | XELB | 4. nov 2024 | 0.79 | 0.00 |
Xcel Energy | XEL | 4. nov 2024 | 65.82 | -1.30 |
XChange Tec.Inc ADR | XHG | 4. nov 2024 | 0.13 | -7.52 |
XCHG Limited - ADS | XCH | 4. nov 2024 | 19.39 | 0.00 |
Xencor | XNCR | 4. nov 2024 | 21.52 | +1.22 |
Xenetic Biosciences | XBIO | 4. nov 2024 | 3.66 | -10.66 |
Xenia Hotels & Resorts | XHR | 4. nov 2024 | 14.29 | +1.13 |
Xenon Pharmaceuticals | XENE | 4. nov 2024 | 41.71 | +0.05 |
Xeris Biopharma | XERS | 4. nov 2024 | 3.22 | -0.31 |
Xerox | XRX | 4. nov 2024 | 8.39 | +1.21 |
XIAO-I ADR | AIXI | 4. nov 2024 | 6.28 | +9.22 |
Xilio Therapeutics | XLO | 4. nov 2024 | 1.44 | +9.09 |
Xinyuan Real Estate ADR | XIN | 4. nov 2024 | 4.03 | +4.40 |
XOMA | XOMA | 4. nov 2024 | 30.86 | +1.58 |
XOMA A Pref | XOMAP | 4. nov 2024 | 25.75 | -2.73 |
XOMA B Pref | XOMAO | 4. nov 2024 | 25.63 | +0.19 |
Xometry A | XMTR | 4. nov 2024 | 22.06 | -1.87 |
XORTX Therapeutics | XRTX | 4. nov 2024 | 1.35 | -5.59 |
Xos | XOS | 4. nov 2024 | 4.42 | +0.68 |
XP A | XP | 4. nov 2024 | 17.62 | +5.07 |
XPEL | XPEL | 4. nov 2024 | 39.25 | +0.80 |
XPeng A ADR | XPEV | 4. nov 2024 | 12.07 | +4.77 |
Xperi | XPER | 4. nov 2024 | 9.20 | -0.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.